Safety & Compliance

FMCSA Warns About Chantix

May 23, 2008

SHARING TOOLS        | Print Subscribe
Professional truckers should not be taking the anti-smoking drug Chantix, according to a warning issued last week by the Federal Motor Carrier Safety Administration.

According to published reports, the agency issued a warning Thursday advising those giving DOT physicals to not qualify anyone currently using this medication.

The warning came after the Institute for Safe Medication Practices, a nonprofit watchdog group, released a study attacking the drug because of its links to seizures, vision problems, dizziness, heart irregularity, diabetes and more than 100 accidents, including 28 road traffic accidents.

The Federal Aviation Administration also banned the drug for pilots and air traffic controllers.

Pfizer, which makes Chantix, said the report's findings were not inconsistent with the possible side effects already listed on the medication's label.

Comment On This Story

Comment: (Maximum 2000 characters)  
Leave this field empty:
* Please note that every comment is moderated.


We offer e-newsletters that deliver targeted news and information for the entire fleet industry.


ELDs and Telematics

sponsored by
sponsor logo

Scott Sutarik from Geotab will answer your questions and challenges

View All

Sleeper Cab Power

Steve Carlson from Xantrex will answer your questions and challenges

View All